A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses With Titration of TAK-935 in Healthy Japanese Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

November 14, 2020

Study Completion Date

November 14, 2020

Conditions

Healthy Volunteer

Interventions

DRUG

TAK-935

TAK-935 Tablets

DRUG

Placebo

TAK-935 placebo-matching tablets

Trial Locations (1)

Clinical Research Hospital Tokyo, Shinjuku-ku